Company
AboutTeamImpact
Science
Development ModelFocus AreasPipeline
Partnering
Business ModelPartners
Proof
Case StudiesContact
Home / Pipeline

Pipeline.

Composition and maturity are shared publicly. Program-level detail is reserved for qualified partners under NDA.

Pipeline

A growing portfolio of differentiated development programs.

Given the competitive sensitivity of 505(b)(2) development, we share pipeline composition and maturity publicly, and reserve program-level detail for qualified partners.

01
Concept & Selection
02
Formulation Development
03
Scale-Up & Clinical Readiness
04
Technology Transfer / Licensing-Ready
4 Long-Acting Injectable 5 Pre-Filled Syringe 3 Ready-to-Use 3 Lyophilised 3 Emulsions 10+ Oral Solids

Injectable, sterile, and lyophilised figures reflect active pipeline programs. Oral solids figure reflects total products developed to date.

Request a pipeline briefing

Program-level detail — including target product profiles, regulatory pathway, and development timelines — is available to qualified partners and investors under a mutual NDA.

Request Briefing →
Next step

Discuss a program, licence or collaboration.